JNJ

Johnson & Johnson is a multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods. Following its separation of the consumer health segment into Kenvue in 2023, J&J now focuses primarily on its Innovative Medicine and MedTech segments. The Innovative Medicine segment develops treatments for immunology, oncology, neuroscience, cardiovascular, and metabolic diseases. The MedTech segment produces surgical instruments, orthopedic devices, contact lenses, and interventional solutions. Founded in 1886 by Robert, James, and Edward Johnson, J&J is headquartered in New Brunswick, New Jersey. The company has increased its dividend for over 60 consecutive years, making it a Dividend King. J&J's diversified healthcare portfolio and global reach make it one of the most resilient companies in the healthcare sector.